The information provided in this website should not be construed as an offer to sell to any person, or a solicitation of any offer to buy from any person, in any jurisdiction, any interests in any products or funds, nor should it be regarded as an investment product or financial advice or be relied upon for any purpose.

While CLSA Capital Partners Limited, its subsidiaries and their respective directors, officers, employees, agents, contractors and advisers (collectively, the "CLSA Capital Partners Group") use reasonable efforts to obtain information from sources believed to be reliable, the CLSA Capital Partners Group does not make any representation or warranty as to the truth, accuracy or completeness of the information (including statements of opinion or expectation) provided in this website or as to the achievement or reasonableness of any future projections, estimates, prospects or returns or any of the assumptions underlying them. The CLSA Capital Partners Group shall not have any liability (whether arising from negligence or otherwise) for any representations (expressed or implied) contained in, or for any omissions from, the information on this website. None of the information provided in this website has been approved by any governmental or other authority in any jurisdiction.

The investments described in this website were selected to illustrate types of investments that the funds sponsored by the CLSA Capital Partners Group may pursue. Therefore, these investments are not indicative of future investments or the actual or anticipated performance of the funds, sponsored by the CLSA Capital Partners Group, through which such investments were made, nor should such investments be viewed as representative of the portfolio of investments held by such funds.

The content provided in this website is, unless otherwise specified, directed at residents of the United States and not intended for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to law or regulation or which would subject the CLSA Capital Partners Group to any registration or other requirement within such jurisdiction. Access to this website may be limited with respect to any person, geographic region or jurisdiction, and the information contained in this website is subject to change without notice

As a result of the global outbreak of COVID-19, there have been substantial disruptions in the global financial system. As a result of these disruptions, we are relying on the relief granted in the SEC Order provided in Release IA-5469 from the requirement to file our annual amendment to Form ADV on or before 30 March 2020. We will update our Form ADV before 15 May 2020.


In accordance with the Financial Instruments and Exchange Law of Japan, certain information is made available for Japanese investors upon request. Please email us at Capital.Partners@clsa.com.


当サイトに掲載しているCLSA Capital Partners Limitedの運用するファンド(以下「ファンドという。」)に関する情報は、投資に対する助言または販売の勧誘を目的としたものではありません。またこれらの情報は特定の金融商品等の売買の推奨又は投資助言を意図したものではありません。



About the Strategy

Building on CITIC Securities' edges in China market, CLSA China growth strategy (the "Strategy") is a USD Private Equity strategy designed for global investors who wish to tap into China’s primary markets. The Strategy invests in companies with the potential for rapid growth in burgeoning sectors of strategic importance in the world’s second-largest economy.

With unparalleled China-market resources dedicated to the Strategy, it is well positioned to become a one-stop-shop for identifying highly sought-after investment opportunities and achieving superior returns for global investors in an ever-changing landscape.

Investment Strategy

Featuring a consistent investment philosophy the Strategy invests in leading players in verticals of target sectors, including healthcare, TMT, smart manufacturing and renewable energies. The Strategy identifies and invests in best-in-class deal pipeline using its sophisticated methodology, and identified investments then go through a strict screening process.

Deal Sourcing

The CLSA China Growth Strategy has an IPO-oriented exit strategy. It is well positioned to invest in portfolio companies with IPO potentials, have meaningful participation in the strategic development of the business and focus on paths to exit, and seek realisation of investments primarily through listing in A-share or Hong Kong capital market.